Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | METAP2 | P50579 | 1/20 | 0.33 |
| ▸ | METAP1 | P53582 | 1/20 | 0.33 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.32 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.31 |
| ▸ | ACE | P12821 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20910230 | 0.79 | FCER2 (0.35) | ACE | |
| SCHEMBL13241294 | 0.79 | CYP2C19 (0.37) | — | |
| SCHEMBL13241298 | 0.79 | ACE (0.31) | ACE | |
| SCHEMBL12992652 | 0.79 | MEN1 (0.34) | METAP2METAP1ACE | |
| SCHEMBL18471723 | 0.79 | METAP2 (0.40) | METAP2METAP1ACE | |
| SCHEMBL13056255 | 0.76 | GABRR1 (0.37) | GABRR1 | |
| SCHEMBL22413378 | 0.76 | GABRR1 (0.52) | GABRR1CPB2 | |
| SCHEMBL13477147 | 0.76 | CA12 (0.34) | ACE | |
| SCHEMBL18935222 | 0.73 | DPP4 (0.37) | GABRR1 | |
| SCHEMBL16549345 | 0.72 | GABRR1 (0.33) | GABRR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11773199-B2 | Auto-invertible inverse polymer emulsion | SNF GROUP (FR) | 2023-10-03 | — | — | US | disclosed |
| US-20230126767-A1 | AUTO-INVERTIBLE INVERSE POLYMER EMULSION | SPCM SA (FR) | 2023-04-27 | — | — | US | disclosed |
| US-9492789-B2 | Draw solute for forward osmosis, forward osmosis water treatment device, and forward osmosis method for water treatment | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2016-11-15 | — | — | US | disclosed |
| US-9447239-B2 | Thermosensitive copolymers, forward osmosis water treatment devices including the same, and methods of producing and using the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2016-09-20 | — | — | US | disclosed |
| US-9399193-B2 | Draw solute for forward osmosis, draw solution including the same, forward osmosis water treatment device using the same, and forward osmosis method for water treatment using the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2016-07-26 | — | — | US | disclosed |
| US-20130240444-A1 | THERMOSENSITIVE COPOLYMERS, FORWARD OSMOSIS WATER TREATMENT DEVICES INCLUDING THE SAME, AND METHODS OF PRODUCING AND USING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2013-09-19 | — | — | US | disclosed |
| US-20130180919-A1 | DRAW SOLUTE FOR FORWARD OSMOSIS, FORWARD OSMOSIS WATER TREATMENT DEVICE, AND FORWARD OSMOSIS METHOD FOR WATER TREATMENT | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2013-07-18 | — | — | US | disclosed |
| US-20120211423-A1 | DRAW SOLUTE FOR FORWARD OSMOSIS, DRAW SOLUTION INCLUDING THE SAME, FORWARD OSMOSIS WATER TREATMENT DEVICE USING THE SAME, AND FORWARD OSMOSIS METHOD FOR WATER TREATMENT USING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2012-08-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130180919-A1 | DRAW SOLUTE FOR FORWARD OSMOSIS, FORWARD OSMOSIS WATER TREATMENT DEVICE, AND FORWARD OSMOSIS METHOD FOR WATER TREATMENT | AQP1, AQP3, AQP4 | METAP2 4275/4885METAP1 4091/4885GABRR1 3823/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.